Calidi Biotherapeutics, Inc. (CLDI)
EBITDA Growth
13.08%
TTM · Period ending:
CLDI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported13.08%period ending
Latest reported13.08%period ending
CLDI TTM EBITDA YoY % (-183.87% → 13.08%)
Year-over-year change
High-resolution chart · PNG
CLDI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 13.0815% | |
| 3.0649% | |
| 8.0524% | |
| 23.4031% | |
| 13.1452% | |
| 35.1282% | |
| 26.3888% | |
| 15.0931% | |
| 34.4526% | |
| -13.0118% | |
| -16.2564% | |
| -63.7894% | |
| -141.9321% | |
| -183.8738% |